COPD AWARENESS SURVEY: DO BELGIAN PULMONARY PHYSICIANS COMPLY WITH THE GOLD GUIDELINES 2010?
Chronic Obstructive Pulmonary Disease (COPD) is underestimated, underdiagnosed and often undertreated in the general population. A survey of 17 structured questions, delivered to all Belgian pulmonary physicians (PPs) (116 responses), evaluated diagnosis and treatment strategies in accordance with t...
Gespeichert in:
| Veröffentlicht in: | Acta clinica belgica (English ed. Online) Jg. 68; H. 5; S. 325 - 340 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , |
| Format: | Journal Article |
| Sprache: | Englisch |
| Veröffentlicht: |
England
Taylor & Francis
01.09.2013
Taylor & Francis Ltd Taylor and Francis |
| Schlagworte: | |
| ISSN: | 1784-3286, 2295-3337, 2295-3337 |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| Abstract | Chronic Obstructive Pulmonary Disease (COPD) is underestimated, underdiagnosed and often undertreated in the general population. A survey of 17 structured questions, delivered to all Belgian pulmonary physicians (PPs) (116 responses), evaluated diagnosis and treatment strategies in accordance with the Global Initiative for Chronic Obstructive Lung Disease (GOLD) guidelines 2010 and assessed opinions about the importance of diurnal variation of COPD symptoms. All COPD diagnoses (37% new cases) were spirometry confirmed. Main diagnostic parameters were symptoms (99%), external risk factors (99%), clinical examination (97%), exacerbations (96%) and patient mobility (96%). FEV
1
(forced expiratory volume in 1s) (97%) or FEV
1
/FVC (ratio of FEV
1
to forced vital capacity) (93%) were used most to assess diagnosis and severity. The 3 most important therapeutic objectives were symptom relief, preventing exacerbations, and improving quality of life; if these were not reached, the preferred strategy (60% of PPs) was adding another medication. Treatment strategies varied with COPD stage: short-acting β2-agonists (90%) and short-acting anti-cholinergics (59%) were used for GOLD I disease, whereas for higher stages long-acting β2-agonists (36-48%) and long-acting anti-cholinergics (79%) were given with inhaled corticosteroids (21-67%). Symptoms were perceived to vary throughout the day, affecting quality of life (97%) and mobility (89%). In particular, respiratory symptoms were more severe in the morning (51-92%), leading PPs to adapt treatment (69%). This survey demonstrated that management of COPD by PPs in Belgium is generally in line with the GOLD guidelines 2010 and that they perceive morning symptoms as being frequent and having an impact on patient's life. |
|---|---|
| AbstractList | Chronic Obstructive Pulmonary Disease (COPD) is underestimated, underdiagnosed and often undertreated in the general population. A survey of 17 structured questions, delivered to all Belgian pulmonary physicians (PPs) (116 responses), evaluated diagnosis and treatment strategies in accordance with the Global Initiative for Chronic Obstructive Lung Disease (GOLD) guidelines 2010 and assessed opinions about the importance of diurnal variation of COPD symptoms. All COPD diagnoses (37% new cases) were spirometry confirmed. Main diagnostic parameters were symptoms (99%), external risk factors (99%), clinical examination (97%), exacerbations (96%) and patient mobility (96%). FEV
1
(forced expiratory volume in 1s) (97%) or FEV
1
/FVC (ratio of FEV
1
to forced vital capacity) (93%) were used most to assess diagnosis and severity. The 3 most important therapeutic objectives were symptom relief, preventing exacerbations, and improving quality of life; if these were not reached, the preferred strategy (60% of PPs) was adding another medication. Treatment strategies varied with COPD stage: short-acting β2-agonists (90%) and short-acting anti-cholinergics (59%) were used for GOLD I disease, whereas for higher stages long-acting β2-agonists (36-48%) and long-acting anti-cholinergics (79%) were given with inhaled corticosteroids (21-67%). Symptoms were perceived to vary throughout the day, affecting quality of life (97%) and mobility (89%). In particular, respiratory symptoms were more severe in the morning (51-92%), leading PPs to adapt treatment (69%). This survey demonstrated that management of COPD by PPs in Belgium is generally in line with the GOLD guidelines 2010 and that they perceive morning symptoms as being frequent and having an impact on patient's life. Chronic Obstructive Pulmonary Disease (COPD) is underestimated, underdiagnosed and often under-treated in the general population. A survey of 17 structured questions, delivered to all Belgian pulmonary physicians (PPs) (116 responses), evaluated diagnosis and treatment strategies in accordance with the Global Initiative for Chronic Obstructive Lung Disease (GOLD) guidelines 2010 and assessed opinions about the importance of diurnal variation of COPD symptoms. All COPD diagnoses (37% new cases) were spirometry confirmed. Main diagnostic parameters were symptoms (99%), external risk factors (99%), clinical examination (97%), exacerbations (96%) and patient mobility (96%). FEV1 (forced expiratory volume in 1s) (97%) or FEV1/FVC (ratio of FEV1 to forced vital capacity) (93%) were used most to assess diagnosis and severity. The 3 most important therapeutic objectives were symptom relief, preventing exacerbations, and improving quality of life; if these were not reached, the preferred strategy (60% of PPs) was adding another medication. Treatment strategies varied with COPD stage: short-acting beta2-agonists (90%) and short-acting anti-cholinergics (59%) were used for GOLD I disease, whereas for higher stages long-acting beta2-agonists (36-48%) and long-acting anti-cholinergics (79%) were given with inhaled corticosteroids (21-67%). Symptoms were perceived to vary throughout the day, affecting quality of life (97%) and mobility (89%). In particular, respiratory symptoms were more severe in the morning (51-92%), leading PPs to adapt treatment (69%). This survey demonstrated that management of COPD by PPs in Belgium is generally in line with the GOLD guidelines 2010 and that they perceive morning symptoms as being frequent and having an impact on patient's life. Chronic Obstructive Pulmonary Disease (COPD) is underestimated, underdiagnosed and often undertreated in the general population. A survey of 17 structured questions, delivered to all Belgian pulmonary physicians (PPs) (116 responses), evaluated diagnosis and treatment strategies in accordance with the Global Initiative for Chronic Obstructive Lung Disease (GOLD) guidelines 2010 and assessed opinions about the importance of diurnal variation of COPD symptoms. All COPD diagnoses (37% new cases) were spirometry confirmed. Main diagnostic parameters were symptoms (99%), external risk factors (99%), clinical examination (97%), exacerbations (96%) and patient mobility (96%). FEV^sub 1^ (forced expiratory volume in 1s) (97%) or FEV^sub 1^/FVC (ratio of FEV^sub 1^ to forced vital capacity) (93%) were used most to assess diagnosis and severity. The 3 most important therapeutic objectives were symptom relief, preventing exacerbations, and improving quality of life; if these were not reached, the preferred strategy (60% of PPs) was adding another medication. Treatment strategies varied with COPD stage: short-acting β^sub 2^-agonists (90%) and shortacting anti-cholinergics (59%) were used for GOLD I disease, whereas for higher stages long-acting β^sub 2^-agonists (36-48%) and long-acting anti-cholinergics (79%) were given with inhaled corticosteroids (21-67%). Symptoms were perceived to vary throughout the day, affecting quality of life (97%) and mobility (89%). In particular, respiratory symptoms were more severe in the morning (51-92%), leading PPs to adapt treatment (69%). This survey demonstrated that management of COPD by PPs in Belgium is generally in line with the GOLD guidelines 2010 and that they perceive morning symptoms as being frequent and having an impact on patient's life. [PUBLICATION ABSTRACT] Chronic Obstructive Pulmonary Disease (COPD) is underestimated, underdiagnosed and often under-treated in the general population. A survey of 17 structured questions, delivered to all Belgian pulmonary physicians (PPs) (116 responses), evaluated diagnosis and treatment strategies in accordance with the Global Initiative for Chronic Obstructive Lung Disease (GOLD) guidelines 2010 and assessed opinions about the importance of diurnal variation of COPD symptoms. All COPD diagnoses (37% new cases) were spirometry confirmed. Main diagnostic parameters were symptoms (99%), external risk factors (99%), clinical examination (97%), exacerbations (96%) and patient mobility (96%). FEV1 (forced expiratory volume in 1s) (97%) or FEV1/FVC (ratio of FEV1 to forced vital capacity) (93%) were used most to assess diagnosis and severity. The 3 most important therapeutic objectives were symptom relief, preventing exacerbations, and improving quality of life; if these were not reached, the preferred strategy (60% of PPs) was adding another medication. Treatment strategies varied with COPD stage: short-acting beta2-agonists (90%) and short-acting anti-cholinergics (59%) were used for GOLD I disease, whereas for higher stages long-acting beta2-agonists (36-48%) and long-acting anti-cholinergics (79%) were given with inhaled corticosteroids (21-67%). Symptoms were perceived to vary throughout the day, affecting quality of life (97%) and mobility (89%). In particular, respiratory symptoms were more severe in the morning (51-92%), leading PPs to adapt treatment (69%). This survey demonstrated that management of COPD by PPs in Belgium is generally in line with the GOLD guidelines 2010 and that they perceive morning symptoms as being frequent and having an impact on patient's life.Chronic Obstructive Pulmonary Disease (COPD) is underestimated, underdiagnosed and often under-treated in the general population. A survey of 17 structured questions, delivered to all Belgian pulmonary physicians (PPs) (116 responses), evaluated diagnosis and treatment strategies in accordance with the Global Initiative for Chronic Obstructive Lung Disease (GOLD) guidelines 2010 and assessed opinions about the importance of diurnal variation of COPD symptoms. All COPD diagnoses (37% new cases) were spirometry confirmed. Main diagnostic parameters were symptoms (99%), external risk factors (99%), clinical examination (97%), exacerbations (96%) and patient mobility (96%). FEV1 (forced expiratory volume in 1s) (97%) or FEV1/FVC (ratio of FEV1 to forced vital capacity) (93%) were used most to assess diagnosis and severity. The 3 most important therapeutic objectives were symptom relief, preventing exacerbations, and improving quality of life; if these were not reached, the preferred strategy (60% of PPs) was adding another medication. Treatment strategies varied with COPD stage: short-acting beta2-agonists (90%) and short-acting anti-cholinergics (59%) were used for GOLD I disease, whereas for higher stages long-acting beta2-agonists (36-48%) and long-acting anti-cholinergics (79%) were given with inhaled corticosteroids (21-67%). Symptoms were perceived to vary throughout the day, affecting quality of life (97%) and mobility (89%). In particular, respiratory symptoms were more severe in the morning (51-92%), leading PPs to adapt treatment (69%). This survey demonstrated that management of COPD by PPs in Belgium is generally in line with the GOLD guidelines 2010 and that they perceive morning symptoms as being frequent and having an impact on patient's life. |
| Author | Vandenberghe, H De Backer, W Decramer, M Corhay, JL Marchand, E De Vuyst, P Degryse, JM Van Craenendonck, V Buffels, J Van den Brande, P Gayan-Ramirez, G Brusselle, G Janssens, W Vincken, W |
| Author_xml | – sequence: 1 givenname: M surname: Decramer fullname: Decramer, M email: marc.decramer@uz.kuleuven.ac.be organization: UZ Leuven Respiratory Division – sequence: 2 givenname: G surname: Brusselle fullname: Brusselle, G organization: Ghent University Hospital Department of Respiratory Medicine – sequence: 3 givenname: J surname: Buffels fullname: Buffels, J organization: University of Leuven (KU Leuven) Department of Public Health and Primary care – sequence: 4 givenname: JL surname: Corhay fullname: Corhay, JL organization: CHU Sart Tilman Department of Pneumology, Liège – sequence: 5 givenname: W surname: De Backer fullname: De Backer, W organization: UZ AntwerpEdegem – sequence: 6 givenname: JM surname: Degryse fullname: Degryse, JM organization: University of Leuven (KU Leuven) Department of Public Health and Primary care – sequence: 7 givenname: W surname: Janssens fullname: Janssens, W organization: UZ Leuven Respiratory Division – sequence: 8 givenname: E surname: Marchand fullname: Marchand, E organization: CHU Mont-Godinne Université Catholique de Louvain, Department of Pneumology – sequence: 9 givenname: P surname: Van den Brande fullname: Van den Brande, P organization: Emmaüs Hospital Network, Respiratory division, Duffel – sequence: 10 givenname: W surname: Vincken fullname: Vincken, W organization: UZ Brussel Vrije Universiteit Brussel, Department of Pneumology – sequence: 11 givenname: G surname: Gayan-Ramirez fullname: Gayan-Ramirez, G organization: UZ Leuven Respiratory Division – sequence: 12 givenname: V surname: Van Craenendonck fullname: Van Craenendonck, V organization: AstraZenecaMedical Affairs – sequence: 13 givenname: H surname: Vandenberghe fullname: Vandenberghe, H organization: AstraZenecaMedical Affairs – sequence: 14 givenname: P surname: De Vuyst fullname: De Vuyst, P organization: Erasme Hospital, Department of Pneumology |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/24579239$$D View this record in MEDLINE/PubMed |
| BookMark | eNptkV1r2zAYhcXoWLOssF8wBLvZjTNJr_yh3QzX8RKDG4d8rAQGQrHl4uJYnexs9N9PJekG23QhCfGcw6tzXqOLznQaobeUTBjl8DFOrifACbxAI8aE7wFAeIFGNIy4BywKLtFV398Tt0DwANgrdMm4HwoGYoS-JcVyiuPbeJUu0vUar7err-nuE54W-DrNZ1m8wMttflMs4tUOL-e7dZa4tzVOiptlvsO32WaON_MUz4p8imfbbJrmmTPCjFDy-Q16Wau211fnc4y2X9JNMvfyYpYlce6VIMTgMVVSXwUqqkNN91FF3dCgVCm4DxDxqq4joD7QICoFE2yvqwDqsCYlUOaHFYMxgpNv2-g7LY3dN_IHk0Y1p_uxvZOqlHstGQsit0XchTRGH06qB2u-H3U_yEPTl7ptVafNsZfUJ5xyAYQ69P1f6L052s79SVLuR6EQhISOenemjvuDruSDbQ7KPsrntB0wOQGlNX1vdS3LZlBDY7rBqqaVlMinRqVrVD41-mfE34Jnz_-g5wyarjb2oH4a21ZyUI-tsbVVXdn0Ev5R_QLxhaT_ |
| CitedBy_id | crossref_primary_10_1136_bmjresp_2022_001478 crossref_primary_10_1186_s41606_017_0019_2 crossref_primary_10_1371_journal_pone_0111078 crossref_primary_10_1371_journal_pone_0095305 crossref_primary_10_1016_j_jclinepi_2016_12_012 crossref_primary_10_1038_s41533_020_0163_5 |
| ContentType | Journal Article |
| Copyright | 2013 President of the Belgian Society of Internal Medicine and President of the Belgian Society for Clinical Biology 2013 Copyright Acta Clinica Belgica 2013 |
| Copyright_xml | – notice: 2013 President of the Belgian Society of Internal Medicine and President of the Belgian Society for Clinical Biology 2013 – notice: Copyright Acta Clinica Belgica 2013 |
| CorporateAuthor | on behalf of the COPD Working Group COPD Working Group |
| CorporateAuthor_xml | – name: on behalf of the COPD Working Group – name: COPD Working Group |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7X7 7XB 88E 8FI 8FJ 8FK 8G5 ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH GNUQQ GUQSH K9. M0S M1P M2O MBDVC PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS Q9U 7X8 Q33 |
| DOI | 10.2143/ACB.3403 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Health & Medical Collection (ProQuest) ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) Research Library (Alumni) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student ProQuest Research Library ProQuest Health & Medical Complete (Alumni) Health & Medical Collection (Alumni) Medical Database Research Library Research Library (Corporate) ProQuest Central Premium ProQuest One Academic (New) ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic (retired) ProQuest One Academic UKI Edition ProQuest Central China ProQuest Central Basic MEDLINE - Academic Université de Liège - Open Repository and Bibliography (ORBI) |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Research Library Prep ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing Research Library (Alumni Edition) ProQuest Central China ProQuest Central ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection ProQuest Research Library ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Central Basic ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE Research Library Prep MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 2295-3337 |
| EndPage | 340 |
| ExternalDocumentID | oai_orbi_ulg_ac_be_2268_228433 3128108111 24579239 10_2143_ACB_3403 11698992 |
| Genre | Research Article Research Support, Non-U.S. Gov't Journal Article |
| GeographicLocations | Belgium |
| GeographicLocations_xml | – name: Belgium |
| GroupedDBID | 4.4 7X7 88E 8FI 8FJ 8G5 AAGDL AALUX AAMIU AAPUL AAQRR ABBKH ABEIZ ABJNI ABLIJ ABUPF ABUWG ABWVI ABXYU ACENM ACGFS ACIEZ ADBBV ADCVX AECIN AENEX AFKRA AFRVT AGDLA AGFJD AGRBW AGYJP AHMBA AIJEM AIRBT AKBVH ALMA_UNASSIGNED_HOLDINGS ALQZU ALYBC AMDAE AQTUD ARJSQ AZQEC BENPR BLEHA BOHLJ BPHCQ BVXVI CCCUG CCPQU DWQXO E01 EBS EJD FYUFA GNUQQ GUQSH H13 HCLVR HMCUK HZ~ IHR KYCEM M1P M2O M4Z O9- P76 P7A P7B PHGZM PHGZT PJZUB PPXIY PQQKQ PROAC PSQYO RNANH RVRKI TASJS TBQAZ TDBHL TERGH TFL TFW TUROJ UEQFS UHWXJ UKHRP 53G AAJKZ AAORF AAYXX ABWCV ABZEW ACKZS ACOPL ACYZI ADFOM ADFZZ AEIIZ AFFHD AFLEI AJVHN BRMBE CITATION CYYVM CZDIS DRXRE DWTOO EMOBN IAO IEA IPNFZ ITC JENTW LJTGL M46 NUSFT QQXMO RIG ADYSH ALIPV CGR CUY CVF ECM EIF NPM 3V. 7XB 8FK K9. MBDVC PKEHL PQEST PQUKI PRINS Q9U 7X8 PUEGO Q33 |
| ID | FETCH-LOGICAL-c399t-2ac15a6a8f7e1b8d12863aac9453384dff83153168c9292bed63f7f0c31257d23 |
| IEDL.DBID | 7X7 |
| ISICitedReferencesCount | 5 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000326144200002&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1784-3286 2295-3337 |
| IngestDate | Sat Nov 29 01:26:30 EST 2025 Fri Sep 05 14:20:41 EDT 2025 Sat Nov 29 14:19:41 EST 2025 Thu Apr 03 07:06:06 EDT 2025 Tue Nov 18 21:37:41 EST 2025 Sat Nov 29 03:55:51 EST 2025 Mon Oct 20 23:45:23 EDT 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 5 |
| Language | English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c399t-2ac15a6a8f7e1b8d12863aac9453384dff83153168c9292bed63f7f0c31257d23 |
| Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 14 ObjectType-Article-1 ObjectType-Feature-2 content type line 23 scopus-id:2-s2.0-84901485380 |
| PMID | 24579239 |
| PQID | 1458799007 |
| PQPubID | 836352 |
| PageCount | 16 |
| ParticipantIDs | proquest_miscellaneous_1504149301 crossref_citationtrail_10_2143_ACB_3403 pubmed_primary_24579239 informaworld_taylorfrancis_310_2143_ACB_3403 proquest_journals_1458799007 crossref_primary_10_2143_ACB_3403 liege_orbi_v2_oai_orbi_ulg_ac_be_2268_228433 |
| PublicationCentury | 2000 |
| PublicationDate | 2013-09-01 |
| PublicationDateYYYYMMDD | 2013-09-01 |
| PublicationDate_xml | – month: 09 year: 2013 text: 2013-09-01 day: 01 |
| PublicationDecade | 2010 |
| PublicationPlace | England |
| PublicationPlace_xml | – name: England – name: Ghent |
| PublicationTitle | Acta clinica belgica (English ed. Online) |
| PublicationTitleAlternate | Acta Clin Belg |
| PublicationYear | 2013 |
| Publisher | Taylor & Francis Taylor & Francis Ltd Taylor and Francis |
| Publisher_xml | – name: Taylor & Francis – name: Taylor & Francis Ltd – name: Taylor and Francis |
| SSID | ssj0000394632 |
| Score | 1.9561424 |
| Snippet | Chronic Obstructive Pulmonary Disease (COPD) is underestimated, underdiagnosed and often undertreated in the general population. A survey of 17 structured... Chronic Obstructive Pulmonary Disease (COPD) is underestimated, underdiagnosed and often under-treated in the general population. A survey of 17 structured... |
| SourceID | liege proquest pubmed crossref informaworld |
| SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 325 |
| SubjectTerms | Belgium Cardiovascular & respiratory systems Chronic obstructive pulmonary disease Circadian Rhythm Clinical medicine COPD Female Guideline Adherence Human health sciences Humans Lung diseases Male Meetings Mortality Pharmaceutical industry Physician's Practice Patterns/statistics & numerical data Physicians Practice Guidelines as Topic Practice Patterns, Physicians' - statistics & numerical data Pulmonary Disease, Chronic Obstructive - diagnosis Pulmonary Disease, Chronic Obstructive - drug therapy Pulmonary Disease, Chronic Obstructive - physiopathology Pulmonary Disease, Chronic Obstructive/diagnosis/drug therapy/physiopathology pulmonary physicians Quality of life Questionnaires Respiratory Function Tests Risk Factors Sciences de la santé humaine Severity of Illness Index survey Surveys and Questionnaires symptoms Systèmes cardiovasculaire & respiratoire treatment strategy |
| SummonAdditionalLinks | – databaseName: Taylor & Francis Online Journals dbid: TFW link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Zi9swEBZlKaUvvY90t0WFQl_q1pZkW-5L8TrOAd4k5Gg2sCBkySoLIVly7O_vSPaGBrYP7YvxMQZ5pNF8o5HnQ-iTrzWXKlYeIdJ44CFKj1MjvSQKtNalYZGsySbiwYBfXiaj5qewbbOt0sbQpi4U4eZqa9yydAwkBNz7tzQ7_0qZK_EJl9Yap535YWHFpwmLHDFZEHPmUcKjuujs0btHbuioSCmg1KXNV_8dcjrX03n6f41-hp40UBOn9dh4jh5Uqxfo0UWTTH-JrrLhqI3TeTrOLfMGnszGP_PFd9we4vO86PbTAR7NCphz0_ECj3qLST-DexOcDS9GxQLP-9MenvZy3B0Wbdyd9dt5YSk8sM18_3iFZp18mvW8hmzBU4BRdh6RKghlJLmJq6DkGvxWRKVUCQNAyJk2hlOYHYOIK0BUpKx0RE1sfEUBIsWa0NfoZLVeVW8RViyhURwk3CQlC3XMFcBM7itjqsqESrbQ5zvdC9VUIreEGEsBEYlVlgBlCausFvp4kLypq2_cI_Plz-4TO7fSYWpaEkHvEXfdK9ab8lrcEmHra7vz_fKXkEqUlQBIyuHAGQXxs7tRIBrr3kK4FPIY3LgfQwMPj8EubbJFrqr1HmRCn0H0CfNnC72pR8_hEwgLbdnG5N2_Nf0UPSaOjMPucDtDJ7vNvnqPHqrb3fV288FZwW95J_4o priority: 102 providerName: Taylor & Francis |
| Title | COPD AWARENESS SURVEY: DO BELGIAN PULMONARY PHYSICIANS COMPLY WITH THE GOLD GUIDELINES 2010? |
| URI | https://www.tandfonline.com/doi/abs/10.2143/ACB.3403 https://www.ncbi.nlm.nih.gov/pubmed/24579239 https://www.proquest.com/docview/1458799007 https://www.proquest.com/docview/1504149301 https://orbi.uliege.be/handle/2268/228433 |
| Volume | 68 |
| WOSCitedRecordID | wos000326144200002&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVPQU databaseName: Health & Medical Collection (ProQuest) customDbUrl: eissn: 2295-3337 dateEnd: 20161130 omitProxy: false ssIdentifier: ssj0000394632 issn: 1784-3286 databaseCode: 7X7 dateStart: 20110101 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: eissn: 2295-3337 dateEnd: 20161130 omitProxy: false ssIdentifier: ssj0000394632 issn: 1784-3286 databaseCode: BENPR dateStart: 20110101 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: Research Library customDbUrl: eissn: 2295-3337 dateEnd: 20161130 omitProxy: false ssIdentifier: ssj0000394632 issn: 1784-3286 databaseCode: M2O dateStart: 20110101 isFulltext: true titleUrlDefault: https://search.proquest.com/pqrl providerName: ProQuest – providerCode: PRVAWR databaseName: Taylor & Francis Online Journals customDbUrl: eissn: 2295-3337 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000394632 issn: 1784-3286 databaseCode: TFW dateStart: 19460101 isFulltext: true titleUrlDefault: https://www.tandfonline.com providerName: Taylor & Francis |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Zi9swEBbtbil96X2k3S4qFPpSd21JtuS-LE7iHJDD5GgSWBCybJWFkGxz7O_vyHbSFrZ96YvwMRiZGc18mhHzIfTRzTKhNNcOIco4ECFSR1CjnDDwsixLDQtUSTbBBwMxn4dJlXDbVscqDz6xcNTZWtsc-YXHfMHBdbr88uaHY1mjbHW1otC4j04tbba1cz7nxxyLS0MWFBxlHhfMoUQEZf9ZAijhImrUv1B2YMuqItIf_UoBsC5t6frv6LOIQq0n_zv_p-hxhT9xVBrMM3QvXz1HD_tVhf0FumoMkyaOZtEotnQceDwdfYsXX3FziOtxr92NBjiZ9sARR6MFTjqLcbcBz8a4MewnvQWedScdPOnEuD3sNXF72m3GPcvrgW05_PIlmrbiSaPjVAwMjgbgsnOI0p6vAiUMz71UZBDMAqqUDhmgRMEyYwQFl-kFQgPMImmeBdRw42oKuIlnhL5CJ6v1Kn-DsGYhDbgXChOmzM-40IA9hauNyXPja1VDnw5akLpqT25ZMpYStilWXxL0Ja2-aujDUfKmbMlxh8zn3xUpd0X6w5RcJZLeIV4oWq436bW8JdI23S6u98vvUmmZ5hJwqoBBMAriZwcdy2rJb-UvBcMEj69hsdoKjFrl6z3I-C6DLSk41Rp6XdrR8RcI820vx_Dtvz_-Dj0iBSOHPeZ2hk52m33-Hj3Qt7vr7ea8sP9iFOfotB4PkhHc9ckQxklr9hMK_Ag_ |
| linkProvider | ProQuest |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V3ZbtNAFB1VBQEv7EugwCCBeMHUy9gzRkKVm7hJVGdRljaRkIbxjAdVipKSpYif4hu54yWAVHjrAy-WZV9Ztuf43DOL70Hota0UE5JKy3WFtiBDpBbztLDCwFFKpZoEojCboN0um0zC_g76Uf0LY5ZVVpyYE7VaSDNGvu8Qn1GgTpsenH-1jGuUmV2tLDQKWBxn379Bl231sd2A9n3jukfxqN6ySlcBS0IyXluukI4vAsE0zZyUKSDowBNChgSUDyNKa-YBDTgBkyAd3DRTgaeptqUHWoAqU-gAKP8a8Dg1nT06odsxHdsLSZB7ojmUEcuDKxf1bl1QJftR_fC9Ryp3rjID_lEfFQTyzEyV_13t5lnv6M7_9r7uotulvsZR8UHcQzvZ_D660SlXEDxAn-q9fgNHp9EgNnYjeDgenMTTD7jRw4dx0mxHXdwfJ5BoosEU91vTYbsOx4a43uv0kyk-bY9aeNSKcbOXNHBz3G7EifEtwWa6_-AhGl_Jsz1Cu_PFPHuCsCShF1AnZDpMia8ok6CtmS21zjLtS1FDb6tW57Isv25cQGYcumEGHxzwwQ0-aujVNvK8KDlyScy734HD1_nwji68WLh3SXgOLL5Ypmf8wuWmqHi-v5l94ULyNOOgwxlsGPEgfK_CFC8pbcV_AQpucHsayMjMMIl5tthAjG8T6HJD0qihxwVut4_gEt_Uqgyf_vviL9HN1qiTcGi842folpu7j5glfXtod73cZM_RdXmxPlstX-TfHkafrxq8PwG6r19i |
| linkToPdf | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1bb9MwFLamDk28cL8UBhgJxAuhuTixg4SmtEkvWtdGvbBVQjKOE6NJVTt6GeKv8es4zqWANHjbAy9RlBxFcfz5nM_2yfkQemWmKROSSsO2hTIgQiQGc5QwfM9K0zRRxBOF2AQdDNjZmR_voR_VvzA6rbLyibmjTpdSr5E3LOIyCq7TpA1VpkXEYfvo4quhFaT0Tmslp1FA5Dj7_g2mb-sPvRD6-rVtt6NJq2uUCgOGhMC8MWwhLVd4gimaWQlLwVl7jhDSJ8CCGEmVYg64BMtjEmiEnWSp5yiqTOkAL6CpLnoA7n-fAskgNbTfjAbxaLfCYzo-8XKFNIsyYjjw7KL6rQ0cpRG0mu8cUml1lfHwj2qpQJfneuP879w3j4Ht2__z17uDbpXMGwfFULmL9rLFPXRwUuYW3EefWsM4xMFpMIq0EAkeT0cfo9l7HA5xM-p3esEAx9M-hKBgNMNxdzbuteDaGLeGJ3F_hk97ky6edCPcGfZD3Jn2wqivFU2wTgQ4eoCm19K2h6i2WC6yxwhL4jsetXym_IS4KWUSWDczpVJZplwp6uhNhQAuy8LsWh9kzmGCprHCAStcY6WOXu4sL4piJFfYvP0dRHyTL_yoQqWFO1eY5yDjy1Vyzi9trsuN5-fb-RcuJE8yDgydwYERB8wPK3zx0tmt-S9wwQvuboOb0ntPYpEtt2DjmgQm4xBO6uhRgeFdE2zi6iqW_pN_P_wFOgDMcui746fopp3Lkuhcv0NU26y22TN0Q15uzter5-VAxOjzdaP3J2qzaYI |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=COPD+AWARENESS+SURVEY%3A+DO+BELGIAN+PULMONARY+PHYSICIANS+COMPLY+WITH+THE+GOLD+GUIDELINES+2010%3F&rft.jtitle=Acta+clinica+belgica+%28English+ed.+Online%29&rft.au=Decramer%2C+M&rft.au=Brusselle%2C+G&rft.au=Buffels%2C+J&rft.au=Corhay%2C+JL&rft.date=2013-09-01&rft.issn=1784-3286&rft.eissn=2295-3337&rft.volume=68&rft.issue=5&rft.spage=325&rft.epage=340&rft_id=info:doi/10.2143%2FACB.3403&rft.externalDBID=n%2Fa&rft.externalDocID=10_2143_ACB_3403 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1784-3286&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1784-3286&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1784-3286&client=summon |